We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for October 29th
Read MoreHide Full Article
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 29th:
ConnectOne Bancorp, Inc. (CNOB - Free Report) : This bank holding company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.
Frontline Ltd. (FRO - Free Report) : This shipping company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
HOYA Corporation (HOCPY - Free Report) : This life care and information technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 3.3% over the last 60 days.
M/I Homes, Inc. (MHO - Free Report) : This builder of single-family homes has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for October 29th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 29th:
ConnectOne Bancorp, Inc. (CNOB - Free Report) : This bank holding company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.
ConnectOne Bancorp, Inc. Price and Consensus
ConnectOne Bancorp, Inc. price-consensus-chart | ConnectOne Bancorp, Inc. Quote
ConnectOne Bancorp’s shares gained 10.5% over the last one month above the S&P 500’s increase 2.1%. The company possesses a Momentum Score of A.
ConnectOne Bancorp, Inc. Price
ConnectOne Bancorp, Inc. price | ConnectOne Bancorp, Inc. Quote
Frontline Ltd. (FRO - Free Report) : This shipping company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Frontline Ltd. Price and Consensus
Frontline Ltd. price-consensus-chart | Frontline Ltd. Quote
Frontline’s shares gained 13.7% over the last one month. The company possesses a Momentum Score of A.
Frontline Ltd. Price
Frontline Ltd. price | Frontline Ltd. Quote
HOYA Corporation (HOCPY - Free Report) : This life care and information technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 3.3% over the last 60 days.
Hoya Corp. Price and Consensus
Hoya Corp. price-consensus-chart | Hoya Corp. Quote
HOYA Corporation’s shares gained 2.8% over the last one month. The company possesses a Momentum Score of A.
Hoya Corp. Price
Hoya Corp. price | Hoya Corp. Quote
M/I Homes, Inc. (MHO - Free Report) : This builder of single-family homes has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.
M/I Homes, Inc. Price and Consensus
M/I Homes, Inc. price-consensus-chart | M/I Homes, Inc. Quote
M/I Homes’ shares gained 16.7% over the last one month. The company possesses a Momentum Score of A.
M/I Homes, Inc. Price
M/I Homes, Inc. price | M/I Homes, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>